Tirzepatide, a dual-acting GLP-1/GIP agonist, stimulates receptors that control appetite, regulate blood sugar, and improve insulin sensitivity
Overuse of active ingredients: combining acids, retinoids, vitamin C, peptides, AHAs, and BHAs all at once
Thus, depression in T2DM may stem from metabolic dysfunctions/MetS alongside diminished PON1 and HDL-C levels
Abstract Glucagon-like peptide-1 (GLP-1) is a gut-derived hormone essential for maintaining glucose homeostasis through multiple physiological pathways: triggering insulin release, inhibiting glucagon secretion, delaying gastric emptying, enhancing feelings of fullness, and suppressing appetite
PubMed Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P, et al
Tirzepatide may interact with other substances